Gufic Biosciences Limited
₹402.00▼ -6.45 (-1.58%)
GUFICBIO·NSE·Healthcare
Market Cap
4042.89 Cr
PE Ratio
63.81
Volume
29,583
Day High - Low
409.45 - 402.00
52W High-Low
467.80 - 268.00
₹402.00▼ -6.45 (-1.58%)
Market Cap4042.89 Cr
PE Ratio63.81
Volume29,583
Day High - Low409.45 - 402.00
52W High-Low467.80 - 268.00
Gufic Biosciences Limited (GUFICBIO): company summary
The company's annual revenue rose 15.1% to ₹944 crore, while annual net profit fell 8.3% to ₹64 crore.
Gufic Biosciences Limited (GUFICBIO) is a micro-cap Healthcare company valued at ₹4,043 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Gufic Biosciences Limited last traded at ₹402, modestly down 1.58% on the day.
- Recent developments
- 2026-08-17: Gufic Biosciences reported a strong Q1 FY27 performance with net profit jumping 70% year-on-year to ₹22 crore for the quarter ended June 2026.
- Financial performance
- The company's annual revenue rose 15.1% to ₹944 crore, while annual net profit fell 8.3% to ₹64 crore. The latest quarter saw revenue rise 14.9% year-on-year to ₹261 crore, and net profit surged 85.9% to ₹22 crore.
- Valuation multiples
- The stock trades at 63.8 times earnings, a premium to the Healthcare median of 32.0, 6.52 times book value. It yields 0.0%.
- Things to watch
- The company's net profit margin narrowed 1.7 percentage points to 6.8%. Return on equity is 0.0%, and net profit fell 8.3% year-on-year. The stock is 10.6% below its 52-week high.
- Where it stands
- The company's latest quarter showed a significant rise in net profit, but annual net profit fell. The stock is trading below its 52-week high, and the net profit margin has declined.
Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
4.5/10
Weak
Fair Value
Sign in to see
ROE
0.00%
Weak
P/E
63.81x
Expensive
Debt / Equity
0.58
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
Day₹402.00
₹409.45
52W₹268.00
₹467.80
DocStoX take
Supported by risk (7.5) and momentum (7.4), but held back by valuation (0.0). Risk looks strong at 7.5, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence4.5
/10
Weak
Quality
Modest
ROE 0.0%
Valuation
Expensive
P/E 63.8×
Growth
Slow
Revenue +14.1% 5Y CAGR
Risk
Low risk
D/E 0.58
Momentum
Firm
67% of 52-week range
At a glance
Market Cap
₹4,043 Cr
52W High / Low
₹468 / ₹268
Dividend Yield
0.02%
Promoter Holding
72.50%
EPS (TTM)
₹6.30
Book Value
₹66.31
Key highlights
- Profitable in all of the last 5 years
- Valuation is weak (0.0/10)
- Expensive at 64× earnings
1 Positive2 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Gufic Biosciences Limited’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Gufic Biosciences Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Gufic Biosciences Limited with peers
Gufic Biosciences Limited vs Sun Pharmaceutical Industries LimitedGufic Biosciences Limited vs Divi's Laboratories LimitedGufic Biosciences Limited vs Torrent Pharmaceuticals LimitedGufic Biosciences Limited vs Apollo Hospitals Enterprise LimitedGufic Biosciences Limited vs Zydus Lifesciences LimitedGufic Biosciences Limited vs Laurus Labs Limited
Related tools & concepts
Value Gufic Biosciences Limited with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing